应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
休市中 09-04 16:08:03
4.435
+0.025
+0.57%
最高
4.490
最低
4.415
成交量
1,008万
今开
4.435
昨收
4.410
日振幅
1.70%
总市值
278.65亿
流通市值
278.63亿
总股本
62.83亿
成交额
4,497万
换手率
0.16%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华润医药子公司获准注册发行10亿元中期票据
公告速递 · 09-01
华润医药子公司获准注册发行10亿元中期票据
华润医药:交易商协会公告发布
美股速递 · 09-01
华润医药:交易商协会公告发布
华润医药更新2026年8月股份变动月报表,股本维持稳定
公告速递 · 09-01
华润医药更新2026年8月股份变动月报表,股本维持稳定
华润医药2026年上半年营收1115.62亿元
公告速递 · 08-31
华润医药2026年上半年营收1115.62亿元
华润医药(03320.HK):华润医药商业上半年归母净利润9.3亿元 同比增加3.45%
智通财经 · 08-31
华润医药(03320.HK):华润医药商业上半年归母净利润9.3亿元 同比增加3.45%
华润医药(03320):华润医药控股上半年归母净利润18.15亿元 同比增加3.13%
智通财经 · 08-31
华润医药(03320):华润医药控股上半年归母净利润18.15亿元 同比增加3.13%
华润医药2026年上半年营收1353.45亿元,经调整净利润51.76亿元
公告速递 · 08-31
华润医药2026年上半年营收1353.45亿元,经调整净利润51.76亿元
大行评级丨美银:下调华润医药目标价至5.7港元,重申“买入”评级
格隆汇 · 08-27
大行评级丨美银:下调华润医药目标价至5.7港元,重申“买入”评级
大行评级丨里昂:下调华润医药目标价至6.5港元,下调收入及净利润预测
中金财经 · 08-27
大行评级丨里昂:下调华润医药目标价至6.5港元,下调收入及净利润预测
美银证券:降华润医药(03320.HK)目标价至5.7港元 重申“买入”评级
智通财经 · 08-26
美银证券:降华润医药(03320.HK)目标价至5.7港元 重申“买入”评级
里昂:维持华润医药(03320.HK)“跑赢大市”评级 目标价下调至6.5港元
智通财经 · 08-26
里昂:维持华润医药(03320.HK)“跑赢大市”评级 目标价下调至6.5港元
华润医药(03320)发布中期业绩,股东应占溢利21.87亿元,同比增长5.3%
智通财经 · 08-24
华润医药(03320)发布中期业绩,股东应占溢利21.87亿元,同比增长5.3%
华润医药(03320)公布2026财年中期股息 每股派0.087元人民币
公告速递 · 08-24
华润医药(03320)公布2026财年中期股息 每股派0.087元人民币
华润医药(03320)将于10月30日派发中期股息每股0.1006港元
智通财经 · 08-24
华润医药(03320)将于10月30日派发中期股息每股0.1006港元
华润医药(03320.HK):天士力医药上半年股东应占净利润8.93亿元 同比增长15.23%
智通财经 · 08-21
华润医药(03320.HK):天士力医药上半年股东应占净利润8.93亿元 同比增长15.23%
华润医药(03320)公布华润三九2026年中期业绩:营收150.14亿元、净利16.71亿元
公告速递 · 08-21
华润医药(03320)公布华润三九2026年中期业绩:营收150.14亿元、净利16.71亿元
华润医药(03320)披露昆药集团2026年上半年未经审计业绩:营收同比降50.97%,归母净亏3.64亿元
公告速递 · 08-21
华润医药(03320)披露昆药集团2026年上半年未经审计业绩:营收同比降50.97%,归母净亏3.64亿元
华润医药(03320):华润三九上半年归母净利润约16.71亿元 同比减少7.96%
智通财经 · 08-21
华润医药(03320):华润三九上半年归母净利润约16.71亿元 同比减少7.96%
华润医药旗下昆药集团半年营收16.4亿元,同比下滑50.97%
美股速递 · 08-21
华润医药旗下昆药集团半年营收16.4亿元,同比下滑50.97%
华润医药(03320):华润江中中期股东应占净利润4.91亿元 同比减少5.92%
智通财经 · 08-21
华润医药(03320):华润江中中期股东应占净利润4.91亿元 同比减少5.92%
加载更多
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家主要从事医药业务的投资控股公司。该公司通过四个分部运营业务。制药业务分部研发、制造及销售一系列药品及保健品。药品分销业务分部向医院、分销商及零售药店等药品制造商、器械制造商及配药商提供分销、仓储、物流及其他药品供应链增值解决方案及相关服务。药品零售业务分部经营零售药店。其他业务营运分部从事持有物业及其他业务。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.435,"timestamp":1788509283006,"preClose":4.41,"halted":0,"volume":10075658,"delay":0,"changeRate":0.005668934240362691,"floatShares":6282510461,"shares":6283000000,"eps":0.7519671722058883,"marketStatus":"休市中","change":0.025,"latestTime":"09-04 16:08:03","open":4.435,"high":4.49,"low":4.415,"amount":44970405,"amplitude":0.017007,"askPrice":4.455,"askSize":500,"bidPrice":4.435,"bidSize":138500,"shortable":3,"etf":0,"ttmEps":0.7744657276177037,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":7,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.41,"dividendRate":0.049132,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":0.9796014695065262,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"1156483718","title":"华润医药子公司获准注册发行10亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1156483718","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156483718?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:50","pubTimestamp":1788256255,"startTime":"0","endTime":"0","summary":"2026年9月1日,华润医药集团有限公司(03320,以下简称“华润医药”)公告称,其非全资附属公司昆药集团股份有限公司已收到中国银行间市场交易商协会出具的《接受注册通知书》(中市协注[2026]MTN682号)。\n\\n\\n通知书自发出日期起两年内有效。在此期间,昆药集团可分期发行总额不超过人民币10亿元的中期票据,发行地为中国银行间债券市场。\n\\n\\n华润医药表示,将在适当时候就拟议发行的具体安排发布进一步公告。公司同时提醒股东及潜在投资者,相关中期票据发行存在可能进行或不进行的情形,买卖公司证券时应保持审慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107134029","title":"华润医药:交易商协会公告发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1107134029","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107134029?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:50","pubTimestamp":1788256215,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK)方面传来最新动态——中国银行间市场交易商协会已就该公司相关事宜正式发布公告。此次公告的发出,无疑为市场参与者提供了新的关注焦点,也引发了投资者对该公司后续动向的密切关注。作为港股医药板块的重要成员,华润医药的每一步动作都备受资本市场瞩目。此番由全国性自律组织所披露的信息,其具体内容及潜在影响,有待各方进一步解读与分析。市场人士普遍认为,相关公告的发布或将对公司短期市场表现产生一定影响,但长期走势仍取决于其基本面与行业环境。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168361489","title":"华润医药更新2026年8月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1168361489","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168361489?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:51","pubTimestamp":1788252717,"startTime":"0","endTime":"0","summary":"华润医药(03320)于2026年9月1日公布了截至2026年8月31日的股份变动月报表。报告显示,公司全称为华润医药集团有限公司,在本期内未发生新增发行、回购或注销及库藏股等变动。\n根据公告披露,截至8月31日,华润医药普通股股份总数为6,282,510,461股,与上月底保持一致,库藏股份数目为0股,股本规模无变化。上述期间,公司股份期权计划项下未发行新股,期末可行使股份期权数量合计为628,450,646份,与上月底结存数相同。\n公告还指出,公司已符合香港联合交易所有限公司《上市规则》要求的最低公众持股量规范。截至2026年8月底,公司股本规模保持稳定,公告由公司秘书温詠宜签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182084083","title":"华润医药2026年上半年营收1115.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182084083","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182084083?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:26","pubTimestamp":1788172014,"startTime":"0","endTime":"0","summary":"本季度信息\n2026年1–6月,华润医药实现营业收入约1115.62亿元,同比上涨约2.87%。本期营业成本约1045.23亿元,较上年同期增加约2.99%。销售费用约27.81亿元,同比上升约6.81%。管理费用约11.75亿元,同比下降约5.09%。研发费用约0.14亿元,同比降幅约39.57%。财务费用约6.94亿元,较上年同期减少约7.47%。报告期内公司经营性现金流量净额为-21.02亿元,相较上年同期的-33.79亿元明显改善。\n","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074132","title":"华润医药(03320.HK):华润医药商业上半年归母净利润9.3亿元 同比增加3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074132","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663074132?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:23","pubTimestamp":1788171837,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663324074","title":"华润医药(03320):华润医药控股上半年归母净利润18.15亿元 同比增加3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663324074","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663324074?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:11","pubTimestamp":1788171081,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,公司的全资附属公司华润医药控股有限公司(华润医药控股)截至2026年6月30日止6个月取得营业收入人民币1353.45亿元(单位下同),同比增加1.93%;归属于母公司所有者的净利润18.15亿元,同比增加3.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华润医药(03320):华润医药控股上半年归母净利润18.15亿元 同比增加3.13%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196210205","title":"华润医药2026年上半年营收1353.45亿元,经调整净利润51.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196210205","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196210205?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:07","pubTimestamp":1788170835,"startTime":"0","endTime":"0","summary":"截至2026年6月30日,华润医药实现营收1353.45亿元,同比增长1.93%。经调整净利润为51.76亿元,同比下滑1.28%。同期经营利润为64.03亿元,经营利润率约4.73%,较上年同期小幅下降。报告期内,公司毛利率约16.71%,与上年同期的16.86%相比基本保持稳定。销售及管理费用合计133.83亿元,较上年同期小幅增长约1.79%。研发投入约11.13亿元,较上年同期的9.71亿元增长约14.66%,占营收比重为0.82%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662772258","title":"大行评级丨美银:下调华润医药目标价至5.7港元,重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662772258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662772258?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:15","pubTimestamp":1787800523,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662722687","title":"大行评级丨里昂:下调华润医药目标价至6.5港元,下调收入及净利润预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2662722687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662722687?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:07","pubTimestamp":1787800023,"startTime":"0","endTime":"0","summary":"里昂发表研报指,华润医药中期收入同比增长2%,净利润同比增长5.3%,大致符合市场预期。毛利率及经营利润率分别下跌0.3及0.4个百分点,主要受分销业务利润率受压的影响。基于中期业绩表现,里昂将华润医药2026至2028年收入预测分别下调3.4%、7%及9.7%,当中制药业务销售预测分别下调7.8%、14.3%及19.6%,净利润预测下调6.4%、10.8%及20.1%。该行将其目标价由7.2港元下调至6.5港元,维持“跑赢大市”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260827/32349383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["EWH","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279158","title":"美银证券:降华润医药(03320.HK)目标价至5.7港元 重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279158","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662279158?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:07","pubTimestamp":1787735270,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796598","title":"里昂:维持华润医药(03320.HK)“跑赢大市”评级 目标价下调至6.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662796598?lang=zh_cn&edition=full","pubTime":"2026-08-26 16:15","pubTimestamp":1787732148,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661856224","title":"华润医药(03320)发布中期业绩,股东应占溢利21.87亿元,同比增长5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661856224","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661856224?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:39","pubTimestamp":1787560747,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药 发布截至2026年6月30日止六个月业绩,收益1344.576亿元,同比增长2%;公司权益股东应占溢利21.87亿元,同比增长5.3%;每股基本盈利0.35元,拟派中期股息每股0.087元。报告期内,集团制药业务实现分部收益244.447亿元,同比略降1.5%。制药业务毛利率为60.3%,较上年同期上升1.0个百分点。报告期内,集团医药零售业务取得收益63.372亿元,同比增长14.9%。其中,高值药品直送业务实现收益约48.3亿元,同比增长28.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华润医药(03320)发布中期业绩,股东应占溢利21.87亿元,同比增长5.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165532940","title":"华润医药(03320)公布2026财年中期股息 每股派0.087元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1165532940","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165532940?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:36","pubTimestamp":1787560560,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司8月24日公告,董事会已宣布截至2026年6月30日止六个月的中期股息,金额为每股0.087元人民币。按照1元人民币兑1.1561港元的汇率换算,对应港币金额为每股0.1006港元。公告显示,股东可选择以人民币或港币收取股息,且可就部分股息行使货币选择权。股东如需更改股息货币选择,须在2026年10月13日16:30前提交相关申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212192","title":"华润医药(03320)将于10月30日派发中期股息每股0.1006港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212192","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661212192?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:35","pubTimestamp":1787560518,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,将于2026年10月30日派发截至2026年6月30日止6个月的中期股息每股0.1006港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1570","VIG","BK4588","BK4585","03320","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226790","title":"华润医药(03320.HK):天士力医药上半年股东应占净利润8.93亿元 同比增长15.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661226790?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:23","pubTimestamp":1787311416,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03320","BK1515","BK1570","BK1161","09939","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166791042","title":"华润医药(03320)公布华润三九2026年中期业绩:营收150.14亿元、净利16.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166791042","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166791042?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:22","pubTimestamp":1787311379,"startTime":"0","endTime":"0","summary":"2026年8月21日,华润医药公告披露,其间接持股63.22%的控股子公司华润三九医药股份有限公司发布截至2026年6月30日止六个月的未审计财务数据。– 截至2026年6月30日,华润三九总资产为558.45亿元,同比2025年12月31日的588.05亿元下降5.03%。– 期内营业总收入150.14亿元,同比增长1.37%。该议案尚待华润三九临时股东大会审议批准。华润医药提示投资者审慎决策,并关注华润三九已于深圳证券交易所网站披露的完整半年度报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115226118","title":"华润医药(03320)披露昆药集团2026年上半年未经审计业绩:营收同比降50.97%,归母净亏3.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115226118","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115226118?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:22","pubTimestamp":1787311365,"startTime":"0","endTime":"0","summary":"2026年8月21日,华润医药公告转述其附属公司所持股的昆药集团股份有限公司截至2026年6月30日止六个月的未经审计财务资料。华润三九医药股份有限公司持有昆药集团约29.08%的权益,昆药集团以华润医药附属公司形式入账。营业总收入:16.43亿元,同比减少50.97%。公告强调,上述数据依据中国公认会计准则编制,未经审计;相关信息仅涵盖昆药集团,未全面反映华润医药集团整体的经营或财务状况。更多详情可参阅昆药集团2026年半年度报告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267958","title":"华润医药(03320):华润三九上半年归母净利润约16.71亿元 同比减少7.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267958","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661267958?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:20","pubTimestamp":1787311244,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布华润三九2026年中期业绩,营业总收入约150.14亿元,同比增长1.37%;上市公司股东应占净利润约16.71亿元,同比减少7.96%;每股基本盈利1元,每10股分配现金股息4.15元( 含税)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186574580","title":"华润医药旗下昆药集团半年营收16.4亿元,同比下滑50.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186574580","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186574580?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:17","pubTimestamp":1787311028,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司近日披露,其下属企业昆药集团在半年报告期内的营业收入为人民币16.4亿元,与去年同期相比,出现了50.97%的显著下降。这一数据反映出该子公司在当前市场环境下面临的挑战与压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0239","BK0188","BK1570","BK1191","600422","03320","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262246","title":"华润医药(03320):华润江中中期股东应占净利润4.91亿元 同比减少5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262246","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262246?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:58","pubTimestamp":1787309880,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布华润江中截至2026年6月30日止6个月业绩,营业总收入19.32亿元人民币,同比减少9.75%;上市公司股东应占净利润4.91亿元,同比减少5.92%;每股基本盈利0.78元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","600750"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.0295},{"period":"1month","weight":-0.0846},{"period":"3month","weight":-0.0338},{"period":"6month","weight":0.0179},{"period":"1year","weight":-0.0365},{"period":"ytd","weight":0.0271}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0276},{"period":"6month","weight":-0.0041},{"period":"1year","weight":0.0236},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家主要从事医药业务的投资控股公司。该公司通过四个分部运营业务。制药业务分部研发、制造及销售一系列药品及保健品。药品分销业务分部向医院、分销商及零售药店等药品制造商、器械制造商及配药商提供分销、仓储、物流及其他药品供应链增值解决方案及相关服务。药品零售业务分部经营零售药店。其他业务营运分部从事持有物业及其他业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.012765},{"month":2,"riseRate":0.7,"avgChangeRate":0.045371},{"month":3,"riseRate":0.5,"avgChangeRate":0.003211},{"month":4,"riseRate":0.7,"avgChangeRate":0.030284},{"month":5,"riseRate":0.5,"avgChangeRate":0.000669},{"month":6,"riseRate":0.3,"avgChangeRate":-0.002129},{"month":7,"riseRate":0.3,"avgChangeRate":-0.023835},{"month":8,"riseRate":0.4,"avgChangeRate":-0.009727},{"month":9,"riseRate":0.3,"avgChangeRate":-0.019467},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.027129},{"month":11,"riseRate":0.4,"avgChangeRate":0.010245},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000965}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}